BioCryst Pharmaceuticals Inc Tangible Net Worth Ratio

Latest as of September 2020: 100.0%

BioCryst Pharmaceuticals Inc tangible net worth ratio. BioCryst Pharmaceuticals Inc (BCRX) has a Tangible Net Worth Ratio of 100.0% as of September 2020. This metric is calculated by deducting intangible assets ($0.00) from net assets ($33.64 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore BCRX year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Tangible NW Ratio

100.0%
Tangible equity / total equity

Net Assets (Equity)

$33.64 Million
USD

Intangible Assets

$0.00
Goodwill, patents, brand value

Total Assets

$176.23 Million
USD

Tangible Net Worth Ratio of BioCryst Pharmaceuticals Inc (1994–2019)

Tangible net worth ratio of BioCryst Pharmaceuticals Inc from 1994 to 2019. This chart shows how BioCryst Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 24 annual periods from 1994 to 2019. As of September 2020, the ratio stands at 100.0%, reflecting net assets of $33.64 Million with intangible assets of $0.00 USD. Check BCRX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

BioCryst Pharmaceuticals Inc Tangible Net Worth Ratio by Year (1994–2019)

BioCryst Pharmaceuticals Inc tangible net worth ratio by year from 1994 to 2019. The table below presents the year-by-year Tangible Net Worth Ratio for BioCryst Pharmaceuticals Inc from 1994 to 2019, covering 24 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see BCRX market cap.

Year Tangible NW Ratio Net Assets (USD) Intangible Assets Total Assets Change (pp)
2019 100.0% $38.25 Million $0.00 $175.28 Million ▲ +0.0 pp
2018 100.0% $49.23 Million $0.00 $146.84 Million ▲ +0.0 pp
2017 100.0% $83.77 Million $0.00 $178.26 Million ▲ +0.0 pp
2016 100.0% $1.58 Million $0.00 $89.85 Million ▲ +0.0 pp
2015 100.0% $47.72 Million $0.00 $124.56 Million ▲ +0.0 pp
2014 100.0% $75.64 Million $0.00 $136.87 Million ▲ +0.0 pp
2011 100.0% $14.81 Million $0.00 $82.21 Million ▲ +0.0 pp
2010 100.0% $66.62 Million $0.00 $110.57 Million ▲ +0.0 pp
2009 100.0% $86.27 Million $0.00 $142.19 Million ▲ +0.0 pp
2008 100.0% $46.43 Million $0.00 $84.69 Million ▲ +0.0 pp
2007 100.0% $64.91 Million $0.00 $142.72 Million ▲ +1.4 pp
2006 98.6% $21.16 Million $290.69K $68.49 Million ▼ -1.1 pp
2005 99.7% $58.44 Million $187.63K $99.25 Million ▲ +0.5 pp
2004 99.2% $29.33 Million $248.59K $32.47 Million ▼ -0.2 pp
2003 99.4% $28.45 Million $179.00K $30.10 Million ▼ -0.4 pp
2002 99.8% $40.13 Million $97.52K $41.30 Million ▲ +0.4 pp
2001 99.4% $56.81 Million $343.02K $59.10 Million ▼ -0.1 pp
2000 99.5% $61.48 Million $280.99K $70.83 Million ▼ -0.2 pp
1999 99.7% $71.40 Million $200.00K $73.40 Million ▲ +0.1 pp
1998 99.6% $27.70 Million $100.00K $29.10 Million ▲ +0.0 pp
1997 99.6% $25.30 Million $100.00K $26.50 Million ▼ -0.4 pp
1996 100.0% $35.40 Million $0.00 $37.10 Million ▲ +0.0 pp
1995 100.0% $11.30 Million $0.00 $13.10 Million ▲ +0.0 pp
1994 100.0% $11.20 Million $0.00 $12.80 Million —
pp = percentage points